More than a year after Johnson & Johnson won the final ruling on talcum powder, studies in ovarian cancer patients are resuming, with the first scheduled to begin on July 12th.
Juries have awarded billions of dollars to women with ovarian cancer or their families after decades of using Johnson & Johnson baby powder and other talcum powder products. This included a 2018 jury award of $ 4.7 billion, which was later reduced to $ 2.1 billion. Johnson & Johnson, which has defended the safety of its products, has also racked up a number of wins, including the final trial in late 2019.
